Здравей те, добри хора и ангели с големи сърца. Дойде време да споделя новини след направената тежка ЖИВОТОСПАСЯВАЩА ОПЕРАЦИЯ.За съжаление след направен ПЕТ-Скенер се устаноха нови тумори сега и в лява лопатка и дясна плешка на тялото.Продължаваме лечението благодарение на всички вас.
Моля ви , дарители продължавайте да ни подкрепяте!
Всяка помощ е безценна за нас.
Благодаря ви от сърце на всеки който се включи и ме подкрепи в тази тежка битка за мен и моето семейство!
Вярвам, че доброто винаги се връща!♡♡♡
Hail to you, good people and angels with big hearts. The time has come for me to share news after a difficult LIFE SAVING SURGERY.Unfortunately after a PET-Scan new tumors have now been found in the left shoulder blade and right shoulder blade of the body.We are continuing treatment thanks to all of you.
Please , donors keep supporting us!
Every help is priceless for us.
Thank you from the bottom of my heart to everyone who joined and supported me in this tough battle for me and my family!
I believe that good always comes back!♡♡♡
The PavelAndreev.ORG platform has clearly outlined rules for paying out the donated funds for medical campaigns. They guarantee that all the funds will be used for the respective treatment and related costs. All documents used for payment can be found in the News section.
6 easy ways to make your donation - bank card, PayPal, ApplePay, GooglePay, Revolut, IBAN.
In the News section you will find information from the initiators of the campaigns.
PavelAndreev.ORG is the safest platform to organize your next campaign.
PavelAndreev.ORG is an international platform for organizing fundraising campaigns managed by the Pavel Andreev Foundation. Headquarters: Bulgaria, Varna, 113 General Kolev Blvd., Nikulitsel Building, company No. 206678629. All donations made through the platform are collected and administered in Bulgaria by the Foundation team. The campaigns are also managed by the central team in Bulgaria. At the moment, the organization is not registered as a local entity in other countries.